Request demo

Combined In Silico and In Vitro Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells

  • Citation
SHARE
Pharmaceuticals (Basel) | 2022

Islam S, Teo T, Kumarasiri M, Slater M, Martin JH, Wang S, Head R., Combined In Silico and In Vitro Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells. Pharmaceuticals 2022, 15(10), 1186. https://doi.org/10.3390/ph15101186

View publication

Related Science Resources

Application of generative AI to design covalent inhibitors of prolyl oligopeptidase
Generative chemistry is revolutionizing drug discovery, using AI to efficiently explore entirely new areas of chemical space in the search for...
What’s new in Flare™ V12: significant enhancements to FEP and structure-based methods
Find out what’s new in Flare V12 in our latest webinar
Flare™ V12 released: Significant improvements to FEP calculations and structure-based methods
We are pleased to announce the release of Flare V12, which introduces a range of new capabilities and enhancements aimed at improving the efficiency,...

Subscribe & Don't Miss Out

Receive our newsletter to be among the first to hear about product releases, case studies, opinion articles, events and more.
Subscribe